Risk Factors for Arteriovenous Fistula Thrombus Development: A Systematic Review and Meta-Analysis

Author:

Zhang Yuhan,Yi Jing,Zhang Rongzhi,Peng Yu,Dong JianliORCID,Sha Liyan

Abstract

<b><i>Background:</i></b> Risk factors like female sex, fistula location, hypertension, albumin, diabetes, arteriovenous graft (AVG), age, and other factors are related to arteriovenous fistula thrombus (AVFT), but the consistency and magnitude of their associations have not been confirmed by meta-analysis. <b><i>Objectives:</i></b> The purpose of this study was to provide a comprehensive and up-to-date synthesis of evidence on the association between potential risk factors and AVFT. <b><i>Methods:</i></b> In this systematic review and meta-analysis, PubMed, Embase, Cochrane Library, and Web of Science databases were searched for articles published up to April 20th, 2022, and cohort, cross-sectional, and case-control studies examining the association (odds ratio [OR]) between potential risk factors and AVFT were identified. The other inclusion criteria were sufficient data for analysis and nonoverlapping datasets, excluding reviews, meta-analyses, and articles with overlapping datasets. Extracted variables included first author, publication year, study type, sample size, percentage of women, vascular access type, risk or protective factors, and measure of association (adjusted estimates of effect of all risk factors). The study protocol is registered at PROSPERO (CRD42020201884) and followed Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. <b><i>Results:</i></b> Among the 27 identified studies, data from 24 cohort, 2 case-control, and 1 cross-sectional study were included in this review. When compared to non-AVFT, our data showed that the significant risk factors were AVG (pooled OR = 6.28, 95% CI = 1.79–22.02, <i>p</i> = 0.004, <i>I</i><sup>2</sup> = 87%), age (pooled OR = 1.06, 95% CI = 1.00–1.13, <i>p</i> = 0.05, <i>I</i><sup>2</sup> = 98%), female sex (pooled OR = 2.62, 95% CI = 2.56–2.69, <i>p</i> &#x3c; 0.00001, <i>I</i><sup>2</sup> = 0%), C-reactive protein (pooled OR = 1.18, 95% CI = 1.08–1.30, <i>p</i> = 0.0005, <i>I</i><sup>2</sup> = 90%), fistula site (distal) (pooled OR = 3.64, 95% CI = 1.74–7.62, <i>p</i> = 0.0006, <i>I</i><sup>2</sup> = 47%), hypertension (pooled OR = 1.21, 95% CI = 1.00–1.47, <i>p</i> = 0.05, <i>I</i><sup>2</sup> = 46%), CD34<sup>+</sup>KDR<sup>+</sup> cell (pooled OR = 1.85, 95% CI = 1.33–2.57, <i>p</i> = 0.0002, <i>I</i><sup>2</sup> = 0%), and eprex use (pooled OR = 5.36, 95% CI = 1.82–15.77, <i>p</i> = 0.002, <i>I</i><sup>2</sup> = 0%). <b><i>Conclusions:</i></b> The meta-analysis suggests that AVG, age, female sex, CRP level, fistula site (distal), hypertension, CD34<sup>+</sup>KDR<sup>+</sup> cell, and the use of eprex are independent risk factors for AVFT. Therefore, clinical medical staff should treat these risk factors carefully, identify them early, and prevent them early to reduce the occurrence of AVFT.

Publisher

S. Karger AG

Subject

Cardiology and Cardiovascular Medicine,Nephrology,Cardiology and Cardiovascular Medicine,Nephrology

Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3